The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Trimosulfa     4-amino-N-(5-methyl-1,2- oxazol-3...

Synonyms: Trimforte, SMX-TMP, TMP-SMX, Co-Trimazole, Sulfameth/TMP, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Sulprim


Psychiatry related information on Sulprim


High impact information on Sulprim


Chemical compound and disease context of Sulprim


Biological context of Sulprim


Anatomical context of Sulprim


Associations of Sulprim with other chemical compounds


Gene context of Sulprim


Analytical, diagnostic and therapeutic context of Sulprim


  1. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group. Schneider, M.M., Hoepelman, A.I., Eeftinck Schattenkerk, J.K., Nielsen, T.L., van der Graaf, Y., Frissen, J.P., van der Ende, I.M., Kolsters, A.F., Borleffs, J.C. N. Engl. J. Med. (1992) [Pubmed]
  2. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. Manges, A.R., Johnson, J.R., Foxman, B., O'Bryan, T.T., Fullerton, K.E., Riley, L.W. N. Engl. J. Med. (2001) [Pubmed]
  3. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. Medina, I., Mills, J., Leoung, G., Hopewell, P.C., Lee, B., Modin, G., Benowitz, N., Wofsy, C.B. N. Engl. J. Med. (1990) [Pubmed]
  4. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. Hardy, W.D., Feinberg, J., Finkelstein, D.M., Power, M.E., He, W., Kaczka, C., Frame, P.T., Holmes, M., Waskin, H., Fass, R.J. N. Engl. J. Med. (1992) [Pubmed]
  5. Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children. Mulenga, V., Ford, D., Walker, A.S., Mwenya, D., Mwansa, J., Sinyinza, F., Lishimpi, K., Nunn, A., Gillespie, S., Zumla, A., Chintu, C., Gibb, D.M. AIDS (2007) [Pubmed]
  6. Reversal of dementia associated with Whipple's disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier. Ryser, R.J., Locksley, R.M., Eng, S.C., Dobbins, W.O., Schoenknecht, F.D., Rubin, C.E. Gastroenterology (1984) [Pubmed]
  7. Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: the relative contribution of non-adherence and drug failure. Lundberg, B.E., Davidson, A.J., Burman, W.J. AIDS (2000) [Pubmed]
  8. Exacerbation of panic disorder in a woman treated with trimethoprim-sulfamethoxazole. Zealberg, J.J., Lydiard, R.B., Christie, S. Journal of clinical psychopharmacology. (1991) [Pubmed]
  9. Acute psychosis associated with oral trimethoprim-sulfamethoxazole therapy. Gregor, J.C., Zilli, C.A., Gotlib, I.H. Canadian journal of psychiatry. Revue canadienne de psychiatrie. (1993) [Pubmed]
  10. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Mermin, J., Ekwaru, J.P., Liechty, C.A., Were, W., Downing, R., Ransom, R., Weidle, P., Lule, J., Coutinho, A., Solberg, P. Lancet (2006) [Pubmed]
  11. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. Stegeman, C.A., Tervaert, J.W., de Jong, P.E., Kallenberg, C.G. N. Engl. J. Med. (1996) [Pubmed]
  12. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. Hirschtick, R.E., Glassroth, J., Jordan, M.C., Wilcosky, T.C., Wallace, J.M., Kvale, P.A., Markowitz, N., Rosen, M.J., Mangura, B.T., Hopewell, P.C. N. Engl. J. Med. (1995) [Pubmed]
  13. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. Stamm, W.E., Guinan, M.E., Johnson, C., Starcher, T., Holmes, K.K., McCormack, W.M. N. Engl. J. Med. (1984) [Pubmed]
  14. Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome. Pape, J.W., Verdier, R.I., Johnson, W.D. N. Engl. J. Med. (1989) [Pubmed]
  15. Therapy of gonorrhea. Comparison of trimethoprim-sulfamethoxazole and ampicillin. Sattler, F.R., Ruskin, J. JAMA (1978) [Pubmed]
  16. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. Talan, D.A., Stamm, W.E., Hooton, T.M., Moran, G.J., Burke, T., Iravani, A., Reuning-Scherer, J., Church, D.A. JAMA (2000) [Pubmed]
  17. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. Ackers, M.L., Puhr, N.D., Tauxe, R.V., Mintz, E.D. JAMA (2000) [Pubmed]
  18. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia. Wilson, J.M., Guiney, D.G. N. Engl. J. Med. (1982) [Pubmed]
  19. The cost-effectiveness of preventing AIDS-related opportunistic infections. Freedberg, K.A., Scharfstein, J.A., Seage, G.R., Losina, E., Weinstein, M.C., Craven, D.E., Paltiel, A.D. JAMA (1998) [Pubmed]
  20. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole. Yogev, R., Moxon, E.R. J. Clin. Invest. (1982) [Pubmed]
  21. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. Longo, D.L., DeVita, V.T., Duffey, P.L., Wesley, M.N., Ihde, D.C., Hubbard, S.M., Gilliom, M., Jaffe, E.S., Cossman, J., Fisher, R.I. J. Clin. Oncol. (1991) [Pubmed]
  22. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. Hooton, T.M., Winter, C., Tiu, F., Stamm, W.E. JAMA (1995) [Pubmed]
  23. Central nervous system Whipple's disease: relapse during therapy with trimethoprim-sulfamethoxazole and remission with cefixime. Cooper, G.S., Blades, E.W., Remler, B.F., Salata, R.A., Bennert, K.W., Jacobs, G.H. Gastroenterology (1994) [Pubmed]
  24. Co-trimoxazole and the thyroid. Smellie, J.M., Bantock, H.M., Thompson, B.D. Lancet (1982) [Pubmed]
  25. Bullous esophageal lesions due to cotrimoxazole: an immune-mediated process? Heer, M., Altorfer, J., Burger, H.R., Wälti, M. Gastroenterology (1985) [Pubmed]
  26. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. Wade, J.C., Schimpff, S.C., Hargadon, M.T., Fortner, C.L., Young, V.M., Wiernik, P.H. N. Engl. J. Med. (1981) [Pubmed]
  27. Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study. Gleckman, R.A. JAMA (1975) [Pubmed]
  28. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea. Johnson, P.C., Ericsson, C.D., DuPont, H.L., Morgan, D.R., Bitsura, J.A., Wood, L.V. JAMA (1986) [Pubmed]
  29. Pentamidine or co-trimoxazole for Pneumocystis carinii pneumonia. Kochen, M.M., Herrmann, C., Goebel, F.D. Lancet (1983) [Pubmed]
  30. Alterations in cysteine proteinase content of rat lung associated with development of Pneumocystis carinii infection. Hayes, D.J., Stubberfield, C.R., McBride, J.D., Wilson, D.L. Infect. Immun. (1991) [Pubmed]
  31. The arylamine N-acetyltransferase (NAT2) polymorphism and the risk of adverse reactions to co-trimoxazole in children. Zielińska, E., Niewiarowski, W., Bodalski, J. Eur. J. Clin. Pharmacol. (1998) [Pubmed]
  32. Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan. Takahashi, T., Kanda, T., Iwamoto, A. Res. Commun. Mol. Pathol. Pharmacol. (2002) [Pubmed]
  33. Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Bartoloni, A., Pallecchi, L., Benedetti, M., Fernandez, C., Vallejos, Y., Guzman, E., Villagran, A.L., Mantella, A., Lucchetti, C., Bartalesi, F., Strohmeyer, M., Bechini, A., Gamboa, H., Rodríguez, H., Falkenberg, T., Kronvall, G., Gotuzzo, E., Paradisi, F., Rossolini, G.M. Emerging Infect. Dis. (2006) [Pubmed]
  34. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. Ma, L., Borio, L., Masur, H., Kovacs, J.A. J. Infect. Dis. (1999) [Pubmed]
  35. Interstitial nephritis caused by trimethoprim-sulfamethoxazole in renal transplant recipients. Smith, E.J., Light, J.A., Filo, R.S., Yum, M.N. JAMA (1980) [Pubmed]
  36. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Anglaret, X., Chêne, G., Attia, A., Toure, S., Lafont, S., Combe, P., Manlan, K., N'Dri-Yoman, T., Salamon, R. Lancet (1999) [Pubmed]
WikiGenes - Universities